ATR inhibitors (ATRi) exhibit synergy with cisplatin in killing HCT-116 colon cancer cells suggesting combinations of ATRi and cisplatin may be useful therapeutically [15, 19]. The gene discussed is ATR; the disease is colonic neoplasm.